Dina Masi

CIK: 0001345281

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INBP

INTEGRATED BIOPHARMA INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

INBP
INTEGRATED BIOPHARMA INC
Dec 9, 2025
Award(A)
Stock Option (Right to Buy)
Direct
140K shares-
INBP
INTEGRATED BIOPHARMA INC
May 21, 2025
Award(A)
Direct
135K shares at avg. $0.09$12K
INBP
INTEGRATED BIOPHARMA INC
May 21, 2025
Disposition(D)
Stock Option (right to buy)
Direct
135K shares-
INBP
INTEGRATED BIOPHARMA INC
Dec 4, 2024
Award(A)
Stock Option (right to buy)
Direct
125K shares-
INBP
INTEGRATED BIOPHARMA INC
Nov 25, 2024
Award(A)
Direct
65K shares at avg. $0.09$6K
INBP
INTEGRATED BIOPHARMA INC
Nov 25, 2024
Disposition(D)
Stock Option (right to buy)
Direct
65K shares-

		Type	Shares	Price		Ownership
Dec 9, 2025	INBP INTEGRATED BIOPHARMA INC	Award(A) Stock Option (Right to Buy)	140,000	-	-	Direct
May 21, 2025	INBP INTEGRATED BIOPHARMA INC	Award(A)	135,000	$0.09	$12,150	Direct
May 21, 2025	INBP INTEGRATED BIOPHARMA INC	Disposition(D) Stock Option (right to buy)	135,000	-	-	Direct
Dec 4, 2024	INBP INTEGRATED BIOPHARMA INC	Award(A) Stock Option (right to buy)	125,000	-	-	Direct
Nov 25, 2024	INBP INTEGRATED BIOPHARMA INC	Award(A)	65,000	$0.09	$5,850	Direct
Nov 25, 2024	INBP INTEGRATED BIOPHARMA INC	Disposition(D) Stock Option (right to buy)	65,000	-	-	Direct

1-6 of 6 transactions

About Masi Dina

Masi Dina (SEC CIK 0001345281) files insider reports with the SEC as Chief Financial Officer of INTEGRATED BIOPHARMA INC (INBP).

Signal8 holds 4 ownership filings by Masi Dina, all Form 4s, filed between Nov 25, 2024 and Dec 10, 2025. Those filings report 6 transactions, from Nov 25, 2024 to Dec 9, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Masi Dina's filings is in HILLSIDE, NJ.

Recent filings by Masi Dina

Dec 9, 2025: Grant or award of INBP derivative securities (Form 4, code A).
May 21, 2025: Grant or award of INBP shares (Form 4, code A).
May 21, 2025: Disposition to issuer transaction of INBP derivative securities (Form 4, code D).
Dec 4, 2024: Grant or award of INBP derivative securities (Form 4, code A).
Nov 25, 2024: Grant or award of INBP shares (Form 4, code A).

Other insiders filing for INTEGRATED BIOPHARMA INC (INBP)

Friedman Eric J, Director
DeSantis Damon, Director
Canarick Robert, Director
Milmoe William H., Director
DESANTIS CARL, 10% Owner
KAY CHRISTINA, Co-Chief Executive Officer

How to read Form 4 transaction codes